TPCW
COLL icon

TD Private Client Wealth’s Collegium Pharmaceutical COLL Stock Holding History

TD Private Client Wealth’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$90.2K Buy
2,491
+252
+11% +$8.61K ﹤0.01% 789
2026
Q1 		$74K Buy
2,239
+232
+12% +$9.82K ﹤0.01% 811
2025
Q4 		$92.9K Hold
2,007
– – ﹤0.01% 775
2025
Q3 		$70.2K Hold
2,007
– – ﹤0.01% 804
2025
Q2 		$59.3K Hold
2,007
– – ﹤0.01% 817
2025
Q1 		$59.9K Hold
2,007
– – ﹤0.01% 780
2024
Q4 		$57.5K Buy
2,007
+300
+18% +$9.93K ﹤0.01% 795
2024
Q3 		$66K Buy
1,707
+483
+39% +$17.2K ﹤0.01% 782
2024
Q2 		$39.4K Buy
1,224
+341
+39% +$11.8K ﹤0.01% 853
2024
Q1 		$34.3K Buy
+883
New +$30.9K ﹤0.01% 878

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

TD Private Client Wealth's COLL Position: Q2 2026 in Review

TD Private Client Wealth increased its Collegium Pharmaceutical (COLL) stake by 11% in Q2 2026, buying an estimated $8.61K and bringing the position to 2,491 shares worth $90.2K. The position accounts for ﹤0.01% of the portfolio, ranked #789.

TD Private Client Wealth first reported a position in COLL in Q1 2024 and has held it in 10 quarters since. The position peaked at $92.9K in Q4 2025. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • TD Private Client Wealth held 2,491 shares of Collegium Pharmaceutical worth $90.2K as of Q2 2026.
  • TD Private Client Wealth bought 252 Collegium Pharmaceutical shares in Q2 2026, an estimated $8.61K.
  • Collegium Pharmaceutical made up ﹤0.01% of TD Private Client Wealth's portfolio in Q2 2026, its #789 holding.
  • TD Private Client Wealth first reported a position in Collegium Pharmaceutical in Q1 2024 and has held it in 10 quarters since.
  • TD Private Client Wealth's Collegium Pharmaceutical position peaked at $92.9K in Q4 2025.
  • 279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on TD Private Client Wealth's 13F filing for Q2 2026, filed 4 Aug 2026.